Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimilife-M2 Tablet PR

Prescription Icon
Prescription Required

Marketer

Lakshya Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimilife-M2 Tablet PR

Diabetic patients using Glucolife Duo tablets, a dual-action antidiabetic medication, manage type 2 diabetes mellitus. This combined formulation regulates blood glucose. Administer Glucolife Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; recognize symptoms like sweating, dizziness, headache, and tremors. Maintain regular meals and carry fast-acting glucose sources (e.g., sugary snacks, juice). Alcohol increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. Contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any heart conditions prior to use; it may be unsuitable. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring, along with blood counts and liver function tests, are essential under your doctor's guidance.

Uses of Glimilife-M2 Tablet PR

Managing Type 2 Diabetes

Major Benefits of Glimilife-M2 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Administer Glimilife-M2 Tablet PR with food.

Common Side effects of Glimilife-M2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimilife-M2 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Glimilife-M2 Tablet PR with a meal.

How Glimilife-M2 Tablet PR works:

Glimilife-M2 Tablet PR combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimilife-M2 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimilife-M2 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Nursing mothers should avoid Glimilife-M2 Tablet PR, as evidence indicates potential infant harm from the medication's toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimilife-M2 Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Glimilife-M2 Tablet PR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment period.

LiverLiverCAUTION

Exercise caution when prescribing Glimilife-M2 Tablet PR to individuals with hepatic impairment. Dosage modification of Glimilife-M2 Tablet PR may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, Glimilife-M2 Tablet PR should typically commence at a reduced dosage; its administration is contraindicated in those with severe liver disease.

What if you forget to take Glimilife-M2 Tablet PR :

Should you forget a dose of Glimilife-M2 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glimilife-M2 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimilife-M2 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Glimilife-M2 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimilife-M2 Tablet PR and seek immediate medical attention.
Glimilife-M2 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimilife-M2 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimilife-M2 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimilife-M2 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimilife-M2 Tablet PR and alcohol is unsafe. Alcohol can worsen Glimilife-M2's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimilife-M2 Tablet PR
150
MRP 182
17% off